loading page

Carnosine-related dipeptides as potential therapeutics against cancer: in silico estimation of activity, synthesis and in vitro analysis
  • +4
  • Klaudia Chmielewska,
  • Justyna Budka,
  • Szymon Kowalski,
  • Mateusz Daśko,
  • Katarzyna Kozlowska-Tylingo,
  • Krystyna Dzierzbicka,
  • Iwona Inkielewicz-Stepniak
Klaudia Chmielewska
Gdańsk University of Technology

Corresponding Author:[email protected]

Author Profile
Justyna Budka
Medical University of Gdansk
Author Profile
Szymon Kowalski
Medical University of Gdansk
Author Profile
Mateusz Daśko
Gdańsk University of Technology
Author Profile
Katarzyna Kozlowska-Tylingo
Gdańsk University of Technology
Author Profile
Krystyna Dzierzbicka
Gdańsk University of Technology
Author Profile
Iwona Inkielewicz-Stepniak
Medical University of Gdansk
Author Profile

Abstract

Background and purpose: Peptides constitute an interesting starting point for drugs, although research on them is quite slowed by the fact that most of them are non-patentable. Given that carnosine, β-Ala-His dipeptide, was found useful in cancer treatment, we aimed to inspect whether its similar structures could also possess such activity. Experimental Approach: The interdisciplinary approach allows for the much more detailed analysis, hence our study presents computational analysis of potential targets and therapeutic activities of dipeptides with β-Ala or His at the N-end, synthesis and in vitro cytotoxicity and apoptosis tests against a chosen cancerous and non-cancerous cell line. Key Results: We preliminarily propose β-Ala-Ala, His-Val and His-Arg as most potent entities, in regard to carnosine, a known anticancer peptide. Conclusion and Implications: An interdisciplinary approach allows for a much more complex analysis and in silico tests should be a standard element of every toxicological report and we hope to popularize that concept worldwide. Peptides indeed possess activity against cancer, with little to no harm to non-cancerous cells, which is highly valuable.